Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway

Human Pathology

Volumn 38, Issue 1, 2007, Pages 120-133

  Zeng, Zhao Yang ^a   Zhou, Yan Hong ^a   Zhang, Wen Ling ^a   Xiong, Wei ^a   Fan, Song Qing ^b   Li, Xiao Ling ^a   Luo, Xiao Min ^a   Wu, Ming Hua ^a   Yang, Yi Xin ^a   Huang, Chen ^a   Cao, Li ^a   Tang, Ke ^a   Qian, Jun ^a   Shen, Shou Rong ^c   Li, Gui Yuan ^a  

^a Central South University   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

cDNA microarray; Nasopharyngeal Carcinoma; Tissue microarray

Indexed keywords

BETA CATENIN; CASEIN KINASE II; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DISHEVELLED ASSOCIATED ACTIVATOR OF MORPHOGENESIS 2 PROTEIN; FRIZZLED PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN; WNT1 PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX CARCINOMA; NUCLEOTIDE SEQUENCE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; BETA CATENIN; CASEIN KINASE II; CLUSTER ANALYSIS; CREB-BINDING PROTEIN; FEMALE; FRIZZLED RECEPTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 33845343269     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.06.023     Document Type: Article

References (43)

1. Yu M.C., and Yuan J.M. Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12 (2002) 421-429
2. Marks J.E., Phillips J.L., and Menck H.R. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 83 (1998) 582-588
3. Lo K.W., To K.F., and Huang D.P. Focus on nasopharyngeal carcinoma. Cancer Cell 5 (2004) 423-428
4. Deng L.W., Jing N., Tan G.L., et al. A common region of allelic loss on chromosome region 3p25.3-26.3 in nasopharyngeal carcinoma. Genes Chromosomes Cancer 23 (1998) 21-25
5. Yang J.B., Tang X.N., and Deng L.W. Detailed deletion mapping of chromosome 9p21-22 in nasopharyngeal carcinoma. Zhonghua Zhong Liu Za Zhi 2 (1999) 419-421 [in Chinese]
6. Huang D.P., Lo K.W., van Hasselt C.A., et al. A region of homozygous deletion on chromosome 9p21-22 in primary nasopharyngeal carcinoma. Cancer Res 54 (1994) 4003-4006
7. Hui A.B., Lo K.W., Leung S.F., et al. Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56 (1996) 3225-3229
8. Mutirangura A., Charuruks N., Shuangshoti S., et al. Identification of distinct regions of allelic loss on chromosome 13q in nasopharyngeal cancer from paraffin embedded tissues. Int J Cancer 83 (1999) 210-214
9. Mutirangura A., Pornthanakasem W., Sriuranpong V., Supiyaphun P., and Voravud N. Loss of heterozygosity on chromosome 14 in nasopharyngeal carcinoma. Int J Cancer 8 (1998) 153-156
10. Feng B.J., Huang W., Shugart Y.Y., et al. Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4. Nat Genet 31 (2002) 395-399
11. Xiong W., Zeng Z.Y., Xia J.H., et al. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res 64 (2004) 1972-1974
12. Zeng Z., Zhou Y., Zhang W., et al. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med 8 (2006) 156-160
13. Sriuranpong V., Mutirangura A., Gillespie J.W., et al. Global gene expression profile of nasopharyngeal carcinoma by laser capture microdissection and complementary DNA microarrays. Clin Cancer Res 10 (2004) 4944-4958
14. Shanmugaratnam K., and Sobin L.H. Histology typing of tumors of the upper respiratory tract and ear. 2nd ed. (1991), Springer-Verlag, Berlin
15. Teo P., Leung S.F., Yu P., Lee W.Y., and Shiu W. A retrospective comparison between different stage classifications for nasopharyngeal carcinoma. Br J Radiol 64 (1991) 901-908
16. Zhou Y.H., Zeng Z.Y., Xiong W., et al. Microdissection and RNA Line-amplification of nasopharyngeal carcinoma tissue. Prog Biochem Biophys 32 (2005) 463-467
17. Brown P. The Brown lab's experimental protocols (2000). http://cmgm.stanford.edu/pbrown/protocols/index.html
18. Li Y., Li Y.L., Tang R., et al. Discovery and analysis of hepatocellular carcinoma genes using cDNA microarrays. J Cancer Res Clin Oncol 128 (2002) 369-379
19. Yao K.T., Zhang H.Y., Zhu H.C., et al. Establishment and characterization of two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus and derived from nasopharyngeal carcinomas. Int J Cancer 45 (1990) 83-89
20. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95 (1998) 14863-14868
21. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403 (2000) 503-511
22. Dennis Jr. G., Sherman B.T., Hosack D.A., et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 (2003) 3
23. Zhang B.C., Nie X.M., Xiao B.Y., et al. Identification of tissue-specific genes in nasopharyngeal epithelial tissue and differentially expressed genes in nasopharyngeal carcinoma by suppression subtractive hybridization and cDNA microarray. Genes Chromosomes Cancer 38 (2003) 80-90
24. Ma J., Zhou J., Fan S.Q., et al. Role of a novel EGF-like domain-containing gene NGX6 in cell adhesion modulation in nasopharyngeal carcinoma cells. Carcinogenesis 26 (2005) 281-291
25. Zeger S.L., and Liang K.Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42 (1986) 121-130
26. Niedobitek G., Agathanggelou A., and Nicholls J.M. Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression tumour cell phenotype and the role of the lymphoid stroma. Semin Cancer Biol 7 (1996) 165-174
27. Emmert-Buck M.R., Bonner R.F., Smith P.D., et al. Laser capture microdissection. Science 274 (1996) 998-1001
28. Wang E., Miller L.D., Ohnmacht G.A., Liu E.T., and Marincola F.M. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 18 (2000) 457-459
29. Giles R.H., van Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 1653 (2003) 1-24
30. Tetsu O., and McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
31. He T.C., Sparks A.B., Rago C., et al. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
32. Lin Y.M., Ono K., Satoh S., et al. Identification of AF17 as a downstream gene of the beta-catenin/T-cell factor pathway and its involvement in colorectal carcinogenesis. Cancer Res 61 (2001) 6345-6349
33. Orford K., Crockett C., Jensen J.P., Weissman A.M., and Byers S.W. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 272 (1997) 24735-24738
34. Sparks A.B., Morin P.J., Vogelstein B., and Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58 (1998) 1130-1134
35. Chan E.F., Gat U., McNiff J.M., and Fuchs E. A common human skin tumor is caused by activating mutations in beta-catenin. Nat Genet 21 (1999) 410-413
36. Pinna L.A. Protein kinase CK2: a challenge to canons. J Cell Sci 115 (2002) 3873-3878
37. Wolf D., Rodova M., Miska E.A., Calvet J.P., and Kouzarides T. Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 277 (2002) 5562-5567
38. Kremenevskaja N., von Wasielewski R., Rao A.S., Schofl C., Andersson T., and Brabant G. Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24 (2005) 2144-2154
39. Lejeune S., Huguet E.L., Hamby A., Poulsom R., and Harris A.L. Wnt5a cloning expression and up-regulation in human primary breast cancers. Clin Cancer Res 1 (1995) 215-222
40. Samowitz W.S., Powers M.D., Spirio L.N., Nollet F., van Roy F., and Slattery M.L. Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 59 (1999) 1442-1444
41. Rimm D.L., Caca K., Hu G., Harrison F.B., and Fearon E.R. Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma. Am J Pathol 154 (1999) 325-329
42. Morrison J.A., Gulley M.L., Pathmanathan R., and Raab-Traub N. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma. Cancer Res 64 (2004) 5251-5260
43. Katoh M., and Katoh M. Identification and characterization of human DAAM2 gene in silico. Int J Oncol 22 (2003) 915-920